Search Results - "Montaner, J S G"

Performance of HIV-1 Drug Resistance Testing at Low-Level Viremia and Its Ability to Predict Future Virologic Outcomes and Viral Evolution in Treatment-Naive Individuals by Gonzalez-Serna, A., Min, J. E., Woods, C., Chan, D., Lima, V. D., Montaner, J. S. G., Harrigan, P. R., Swenson, L. C.

“…Background. Low-level viremia (LLV; human immunodeficiency virus [HIV-1] RNA 50–999 copies/mL) occurs frequently in patients receiving antiretroviral therapy…”
Get full text

High prevalence of food insecurity among HIV-infected individuals receiving HAART in a resource-rich setting by Anema, A., Weiser, S.D., Fernandes, K.A., Ding, E., Brandson, E.K., Palmer, A., Montaner, J.S.G., Hogg, R.S.

“…This study aimed to assess the prevalence and correlates of food insecurity in a cohort of HIV-infected individuals on highly active antiretroviral therapy…”
Get full text

Increases in the availability of prescribed opioids in a Canadian setting by Nosyk, B, Marshall, B.D.L, Fischer, B, Montaner, J.S.G, Wood, E, Kerr, T

“…Abstract Background The nonmedical use of prescribed opioids (POs) has increased across North America over the past decade. Our objective was to identify…”
Get full text

Cancer incidence among HIV‐positive women in British Columbia, Canada: Heightened risk of virus‐related malignancies by Salters, KA, Cescon, A, Zhang, W, Ogilvie, G, Murray, MCM, Coldman, A, Hamm, J, Chiu, CG, Montaner, JSG, Wiseman, SM, Money, D, Pick, N, Hogg, RS

“…Objectives We used population‐based data to identify incident cancer cases and correlates of cancer among women living with HIV/AIDS in British Columbia (BC),…”
Get full text

Condom use among injection drug users accessing a supervised injecting facility by Marshall, B D L, Wood, E, Zhang, R, Tyndall, M W, Montaner, J S G, Kerr, T

“…Although supervised injecting facility (SIF) use has been associated with reductions in injection-related risk behaviours, the impact of SIFs on the sexual…”
Get more information

HIV-Associated Burkitt Lymphoma : Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era by Rodrigo, J. A., Hicks, L. K., Cheung, Matthew C., Song, Kevin, Ezzat, H., Leger, Chantal S., Boro, J., Montaner, Julio S. G., Harris, Marianne, Leitch, Heather A.

“…Background. The outcome of HIV-associated non-Hodgkin lymphoma (NHL) has improved substantially in the highly active antiretroviral therapy (HAART) era…”
Get full text

Predicting HIV RNA Virologic Outcome at 52-Weeks Follow-Up in Antiretroviral Clinical Trials by Raboud, J M, Rae, S, Montaner, J S. G

“…OBJECTIVE:To determine the ability of intermediate plasma viral load (pVL) measurements to predict virologic outcome at 52 weeks of follow-up in clinical…”
Get full text

Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: Outcomes from a population-based cohort by Braitstein, P., Montessori, V., Chan, K., Montaner, J. S. G., Schechter, M. T., O'Shaughnessy, M. V., Hogg, R. S.

“…The objective of the study was to describe the additional burden generated by hepatitis C (HCV) infection among HIV-infected individuals as measured by…”
Get full text

Inadequacies in antiretroviral therapy use among Aboriginal and other Canadian populations by Miller, C. L., Spittal, P. M., Wood, E., Chan, K., Schechter, M. T., Montaner, J. S. G., Hogg, R. S.

“…We undertook this study to provide a profile of Aboriginal people initiating antiretroviral therapy and their response to treatment. Aboriginal peoples were…”
Get full text

An assessment of global Internet-based HIV/AIDS media coverage: implications for United Nations Programme on HIV/AIDS' Global Media HIV/AIDS initiative by Anema, A, Freifeld, C C, Druyts, E, Montaner, J S G, Hogg, R S, Brownstein, J S

“…No studies to date have assessed the quantity of HIV/AIDS-related media on the Internet. We assessed the quantity of language-specific HIV/AIDS Internet-based…”
Get more information

Drastic elevations in mortality among female injection drug users in a Canadian setting by Spittal, P. M., Hogg, R. S., Li, K., Craib, K. J., Recsky, M., Johnston, C., Montaner, J. S. G., Schechter, M. T., Wood, E.

“…The health and social conditions of women living in Vancouver's Downtown Eastside has recently been the focus of substantial international attention. Since few…”
Get full text

Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide by Loutfy, M.R., Raboud, J.M., Montaner, J.S.G., Antoniou, T., Wynhoven, B., Smaill, F., Rouleau, D., Gill, J., Schlech, W., Brumme, Z.L., Mo, T., Gough, K., Rachlis, A., Harrigan, P.R., Walmsley, S.L.

“…In this study, we retrospectively assessed a gp41 genotypic assay in 404 enfuvirtide-naïve individuals (340 clade B, 64 non-B clade) to determine the…”
Get full text

Prevalence and Correlates of Reporting Difficulty Taking Antiretroviral Treatment Among HIV-Positive Illicit Drug Users in Vancouver, Canada: A Longitudinal Analysis by Yeung, Bianca, Mohd Salleh, N. A., Socías, Eugenia, Dong, Huiru, Shoveller, J., Montaner, J. S. G., Milloy, M.-J. S.

“…People living with HIV who use illicit drugs continue to experience high rates of suboptimal treatment outcomes from antiretroviral therapy (ART). Although…”
Get full text

Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone by Braitstein, P., Li, K., Kerr, T., Montaner, J. S. G., Hogg, R. S., Wood, E.

“…Access to HCV (Hepatitis C virus) care for HIV/HCV-co-infected patients is an urgent public health concern. The objective of the present study was to describe…”
Get full text

Outpatient pharmacy care and HIV viral load response among patients on HAART by Castillo, E., Palepu, A., Beardsell, A., Akagi, L., Yip, B., Montaner, J. S. G., Hogg, R. S.

“…Adherence to highly active antiretroviral therapy (HAART) is necessary to achieve long-term effectiveness. The impact of HIV/AIDS-specific pharmacy services on…”
Get full text

A Pilot Study of Nevirapine, Indinavir, and Lamivudine among Patients with Advanced Human Immunodeficiency Virus Disease Who Have Had Failure of Combination Nucleoside Therapy by Harris, M., Durakovic, C., Rae, S., Raboud, J., Fransen, S., Shillington, A., Conway, B., Montaner, J. S. G.

“…The effects of nevirapine, indinavir, and lamivudine in combination were studied among 22 human immunodeficiency virus (HIV)-infected patients with CD4 cell…”
Get full text

Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach by Jacka, B., Bray, B. C., Applegate, T. L., Marshall, B. D. L., Lima, V. D., Hayashi, K., DeBeck, K., Raghwani, J., Harrigan, P. R., Krajden, M., Montaner, J. S. G., Grebely, J.

“…Summary This study estimated latent classes (ie, unobserved subgroups in a population) of people who use drugs in Vancouver, Canada, and examined how these…”
Get full text

Cost-effectiveness Analysis Along the Continuum of HIV Care: How Can We Optimize the Effect of HIV Treatment as Prevention Programs? by Nosyk, B., Krebs, E., Eyawo, O., Min, J. E., Barrios, R., Montaner, J. S. G.

“…The cascade of HIV care has been proposed as a useful tool to monitor health system performance across the key stages of HIV care delivery to reduce morbidity,…”
Get full text

Non‐HIV‐related health care utilization, demographic, clinical and laboratory factors associated with time to initial retention in HIV care among HIV‐positive individuals linked to HIV care by Lourenço, L, Nohpal, A, Shopin, D, Colley, G, Nosyk, B, Montaner, JSG, Lima, VD

“…Objectives The aim of the study was to explore non‐HIV‐related health care service (NHRHS) utilization, demographic, clinical and laboratory factors associated…”
Get full text

Suppression of Plasma Virus Load below the Detection Limit of a Human Immunodeficiency Virus Kit Is Associated with Longer Virologic Response than Suppression below the Limit of Quantitation by Raboud, J. M., Rae, S., Hogg, R. S., Yip, B., Sherlock, C. H., Harrigan, P. R., O'Shaughnessy, M. V., Montaner, J. S. G.

“…Suppression of human immunodeficiency virus type 1 plasma virus load (PVL) to <20 copies/mL is associated with a longer virologic response after initiation of…”
Get full text